Skip to main content
Top
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

The evaluation of four small-field digital mammography systems

Authors: CP Lawinski, D Smith, DS Evans, A Mackenzie, NSA Wells, D Emerton, CA Lewis

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

Continuing developments in diagnostic imaging technology have resulted in the gradual replacement of film screen imaging systems by digital devices. Small-field mammographic imaging is one area in which this new technology has been successfully implemented. These systems are designed primarily for stereotactic localisation, although a number can be additionally used for spot imaging. In the past year, nearly all mammography X-ray units purchased with a stereotactic attachment have been supplied with a digital imaging option. As part of its continuing evaluation programme, KCARE has evaluated the four systems currently offered in the UK. All these are based on charge couple device (CCD) technology. Measurements of breast dose and image quality were made. The use of conventional mammography test objects, although providing relevant image quality data, is made difficult by the limited field size. Thus, additionally, one commercially available and two in-house test objects were employed, all based on a contrast detail format. …
Metadata
Title
The evaluation of four small-field digital mammography systems
Authors
CP Lawinski
D Smith
DS Evans
A Mackenzie
NSA Wells
D Emerton
CA Lewis
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr206

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

MR-guided breast biopsy

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine